文献速递免疫规划

单剂口服非致病性大肠杆菌活疫苗对猪F4阳性产肠毒素大肠杆菌攻击的免疫原性与保护效力

Immunogenicity and protective efficacy of a single-dose live non-pathogenic Escherichia coli oral vaccine against F4-positive enterotoxigenic Escherichia coli challenge in pigs.
PubMed 文献 · Vaccine · 2016-12-01

本研究通过三项盲法、安慰剂对照、区组设计平行组确证试验,采用F4-ETEC断奶后腹泻攻击模型,评估单剂Coliprotec® F4活疫苗经饮水免疫断奶仔猪后在不同接种-攻击间隔(3、7、21天)的保护效果。结果显示疫苗在接种后7天和21天显著降低中重度腹泻发生率、回肠定植和粪便排菌,7天起效与血清抗F4 IgM升高相关,21天保护持续与血清抗F4 IgM和IgA均升高相关。

要点

  • 单剂Coliprotec® F4疫苗经饮水免疫可显著降低7天和21天后F4-ETEC攻击所致中重度腹泻发生率。
  • 7天保护起效与血清抗F4 IgM升高相关,21天保护持续与血清抗F4 IgM和IgA均升高相关。
  • 母源F4特异性血清抗体不干扰疫苗效力,接种后3天攻击可见腹泻严重程度和持续时间及排菌减少。

核心结论

  • 单剂Coliprotec® F4疫苗经饮水给予至少18日龄猪只,其7天起效和21天保护持续时间通过对抗F4-ETEC攻击的保护及诱导F4特异性保护免疫得到确认。

研究设计与样本

  • 三项盲法、安慰剂对照、区组设计、平行组确证试验,采用F4-ETEC断奶后腹泻攻击模型,每项试验的接种-攻击间隔分别为3天、7天和21天。
  • 仔猪在断奶后一天经饮水接种单剂Coliprotec® F4疫苗。
  • 通过评估腹泻、临床观察、肠液蓄积、增重、肠道定植和F4-ETEC粪便排菌评价效力,通过检测血清和肠道F4特异性抗体评价免疫应答。

主要发现

  • 接种后7天和21天异源攻击后,疫苗显著降低中重度腹泻发生率、F4-ETEC回肠定植和粪便排菌。
  • 7天保护起效与血清抗F4 IgM升高相关,21天保护持续与血清抗F4 IgM和IgA均升高相关。
  • 检测到血清与肠道分泌性抗F4抗体水平间存在显著相关性。
  • 母源F4特异性血清抗体不干扰疫苗效力。
  • 接种后3天攻击可见腹泻严重程度和持续时间及F4-ETEC粪便排菌减少。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Enterotoxigenic Escherichia coli strains expressing F4 (K88) fimbriae (F4-ETEC) are one of the most important causes of post-weaning diarrhea (PWD) in pigs. F4, a major antigen, plays an important role in the early steps of the infection. Herein, the efficacy of a live oral vaccine consisting of a non-pathogenic E. coli strain expressing F4 for protection of pigs against PWD was evaluated. Three blinded, placebo-controlled, block design, parallel-group confirmatory experiments were conducted, using an F4-ETEC PWD challenge model, each with a different vaccination-challenge interval (3, 7, and 21days). The pigs were vaccinated via the drinking water with a single dose of the Coliprotec® F4 vaccine one day post-weaning. Efficacy was assessed by evaluating diarrhea, clinical observations, intestinal fluid accumulation, weight gain, intestinal colonization and fecal shedding of F4-ETEC. The immune response was evaluated by measuring serum and intestinal F4-specific antibodies. The administration of the vaccine resulted in a significant reduction of the incidence of moderate to severe diarrhea, ileal colonization by F4-ETEC, and fecal shedding of F4-ETEC after the heterologous challenge at 7 and 21days post-vaccination. The 7-day onset of protection was associated with an increase of serum anti-F4 IgM whereas the 21-day duration of protection was associated with an increase of both serum anti-F4 IgM and IgA. Significant correlations between levels of serum and intestinal secretory anti-F4 antibodies were detected. Maternally derived F4-specific serum antibodies did not interfere with the vaccine efficacy. The evaluation of protection following a challenge three days after vaccination showed a reduction of the severity and the duration of diarrhea and of fecal shedding of F4-ETEC. The 7-day onset and the 21-day duration of protection induced by Coliprotec® F4 vaccine administered once in drinking water to pigs of at least 18days of age were confirmed by protection against F4-ETEC and induction of F4-specific protective immunity.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Fairbrother JM, Nadeau É, Bélanger L, et al. Immunogenicity and protective efficacy of a single-dose live non-pathogenic Escherichia coli oral vaccine against F4-positive enterotoxigenic Escherichia coli challenge in pigs. Vaccine. 2016. PMID: 27916413. doi:10.1016/j.vaccine.2016.11.045

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。